Hereditary Breast and Ovarian Cancer Test

Hereditary Breast and Ovarian Cancer (HBOC) is a genetic predisposition that significantly increases the risk of developing breast and ovarian cancers that is passed down through the family.
Supported by

Hereditary Breast and Ovarian Cancer Test

Hereditary Breast and Ovarian Cancer (HBOC) is a genetic predisposition that significantly increases the risk of developing breast and ovarian cancers that is passed down through the family.
Supported by

What is Hereditary Breast and Ovarian Cancer (HBOC)?

Most cases of breast and ovarian cancer happen by chance. However in some situations, individuals can have harmful changes (called pathogenic variants) in specific genes that convey an increased risk of developing breast and ovarian cancers. These pathogenic variants are inherited (passed from parent to child) and can be detected by genomic testing. A strong family history of breast, ovarian and/or colorectal cancers may suggest pathogenic familial variants.

Approximately 5-10% of breast cancers are due to inherited genetic variants and at least 20%of ovarian cancers are also thought to be hereditary. Genomic testing of BRCA1, BRCA2 and other cancer susceptibility genes can be used to identify patients and relatives with an increased lifetime risk of these and other cancers due to inherited pathogenic variants. Having a genetic variant for HBOC does not guarantee cancer development but elevates the lifetime risk substantially.

Testing for these genetic variants is important is important in two main settings. Diagnostic testing is performed for individuals with a diagnosis or personal history of cancer, and predictive testing is performed in unaffected individuals to determine the future risk of cancer. Awareness of family cancer risk can alter medical care for individuals and their families.

Who should consider testing?

Genetic testing for HBOC might be recommended if you have:

  • A family history of breast or ovarian cancer, especially at young ages.
  • Multiple family members affected by these cancers.
  • A known BRCA pathogenic variant in your family or other familial variant.
  • Personal history of breast cancer, particularly if diagnosed under 60, or if it's triple-negative breast cancer.
  • Ashkenazi Jewish ancestry, which has a higher prevalence of BRCA pathogenic variants.
  • Male breast cancer in the family.

Other reasons for genetic testing may also be considered, and your healthcare provider can help you understand whether you may be a candidate for testing.

Our panels

Genomic Diagnostics offers multiple gene tests and panels for hereditary breast and ovarian cancer.

Genetic counselling is required by our national accreditation body for all tests as the results can have important medical and psychological implications for both you and your family. This counselling can be performed by a qualified genetic counsellor or a medical specialist.

Your request for testing may come from either a general practitioner or a medical specialist, we accept both. There are different pathways to obtain testing, depending on your requesting practitioner. This is due to the requirement for genetic counselling and Medicare.

A specialist can request any of our hereditary breast and ovarian cancer tests. They may do so to direct the use of specific treatments if you currently have cancer, guide risk-reducing surgery, and also to guide in the testing of at-risk family members. Often you will be covered by Medicare for your test.

Medicare does not cover any requests originating with a general practitioner (GP) and GP's are also unable to perform the genetic counselling which must accompany all tests. To enable you to access breast and ovarian cancer genetic testing through your general practitioner, Genomic Diagnostics offers a combined testing and genetic counselling package. This package includes dedicated pre-and post-test genetic counselling sessions with a qualified genetic counsellor along with genetic testing. The counsellors will guide you through what testing means, the potential implications for you and your family members, and what your results mean. This option is often chosen by unaffected individuals.

Patients' process

Step 1

Get a doctor’s request

Your doctor will discuss hereditary breast and ovarian cancer testing with you, ensuring you understand the process, cost (if any) and implications. They will provide a dedicated request form to which you will need to sign your consent to proceed.

Step 2

Have a blood test

Medicare may not cover the cost of this test. If you need to pay for the test, do so here, prior to having your blood taken at your local Healius Pathology collection centre. Write the receipt number on the request form,

Step 3

Genetic counselling

If your request has been signed by a GP or your specialist has requested external genetic counselling, your details will be passed onto our genetic counselling partners, who will contact you directly to arrange a pre-test genetic counselling session.

Step 4

Results consultation with your doctor

Your results will be delivered to your doctors within 4 – 5 weeks after completion of pre-test genetic counselling. If your original request was signed by a general practitioner, these results will also be sent to the genetic counsellor, who will conduct a post-test counselling session with you.

FAQ

Which genes are covered in these tests?
Who should consider having this test?
Why is genetic counselling so important?
What do the results mean?
How do I know if GP referred breast and ovarian cancer testing is right for me?
How long will it take to receive the results?
Does Medicare or private health insurance cover the cost of testing?
What happens is I change my mind about testing?
Refund Policy